Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy

NCT03206645 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Unesbulin

Sponsor

University of Oklahoma

Collaborators

[object Object]